The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: AstraZeneca, Bayer HealthCare
OpenAlex ID: W2106079757
